Infarction Clinical Trials

349 recruitingLast updated: May 29, 2026

There are 349 actively recruiting infarction clinical trials across 51 countries. Studies span Not Applicable, Phase 4, Phase 3, Phase 2, Early Phase 1, Phase 1. Top locations include Beijing, Beijing Municipality, China, Seoul, South Korea, London, United Kingdom. Updated daily from ClinicalTrials.gov.


Infarction Trials at a Glance

349 actively recruiting trials for infarction are listed on ClinicalTrialsFinder across 6 cities in 51 countries. The largest study group is Not Applicable with 132 trials, with the heaviest enrollment activity in Beijing, Seoul, and London. Lead sponsors running infarction studies include Assistance Publique - Hôpitaux de Paris, Queen Mary University of London, and Chonnam National University Hospital.

Browse infarction trials by phase

Treatments under study

About Infarction Clinical Trials

Looking for clinical trials for Infarction? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Infarction trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Infarction clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 349 trials

Recruiting

Ventricular Arrhythmias in Acute Myocardial Infarction

Ventricular ArrhythmiaAcute Myocardial Infarction (AMI)
Poitiers University Hospital500 enrolled8 locationsNCT07517523
Recruiting
Not Applicable

Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With STEMI

ST Elevation Myocardial Infarction
Hospital Universitario La Fe1,272 enrolled23 locationsNCT06353594
Recruiting
Phase 2Phase 3

Minocycline After Successful Endovascular Thrombectomy Recanalization in Acute Anterior Circulation Large Vessel Occlusion (ATTRACTION-MINOA)

Acute Ischemic StrokeMinocyclineAnterior Circulation Brain Infarction+2 more
Xiang Luo860 enrolled1 locationNCT07594314
Recruiting
Not Applicable

Low-dose Interleukin-2 After Myocardial Infarction to Investigate Effects on Tissue-resident Regulatory T Cells

Coronary Artery DiseaseMyocardial Infarction (MI)CABG
Cambridge University Hospitals NHS Foundation Trust24 enrolled2 locationsNCT07610538
Recruiting
Phase 4

Intracoronary rhTNK-tPA Versus Tirofiban in Patients With STEMI and High Thrombus Burden

ST-segment elevation myocardial infarction (STEMI)
Henan Institute of Cardiovascular Epidemiology300 enrolled1 locationNCT06769256
Recruiting
Phase 2

A Research Study to Evaluate the Efficacy and Safety of SGC001 in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction

Anterior Myocardial Infarction
Beijing Sungen Biomedical Technology Co., Ltd210 enrolled1 locationNCT07306182
Recruiting
Not Applicable

Late Reperfusion With Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction

Ischemic Heart DiseaseST Segment Elevation Myocardial Infarction
Thomas Engstrom150 enrolled1 locationNCT02445885
Recruiting
Not Applicable

Cohort of STEMI Patients 2

Myocardial Infarction
Hospices Civils de Lyon300 enrolled2 locationsNCT05794022
Recruiting

Clinical Characteristics, Frailty, and Prognostic Predictors in Patients Aged 75 and Older With Acute Coronary Syndrome

Unstable Angina PectorisST Elevation (STEMI) Myocardial InfarctionNon ST Elevation Myocardial Infarction (NSTEMI)
Clinical Center Niš550 enrolled1 locationNCT07366684
Recruiting
Not Applicable

Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation

Stroke, IschemicStrokeStroke (CVA) or TIA+7 more
Maastricht University Medical Center613 enrolled10 locationsNCT07556887
Recruiting

SuperSaturated Oxygen Comprehensive Observational Registry

STEMI - ST Elevation Myocardial InfarctionAMI
TherOx1,000 enrolled25 locationsNCT06438315
Recruiting

Coronary Microvascular Dysfunction Assessments in Myocardial Infarction With Non-Obstructive Coronary Arteries

Myocardial InfarctionCoronary Microvascular DysfunctionVasospasm, Coronary
Chonnam National University Hospital150 enrolled1 locationNCT05272618
Recruiting

Prediction of LVAR and MACE in STEMI Though Plasma Multiomics Analysis

Major Adverse Cardiovascular EventsLeft Ventricular RemodelingPlasma Multi-Omics+2 more
Beijing Anzhen Hospital1,000 enrolled1 locationNCT06885619
Recruiting

Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI Patients

Myocardial Infarction
Novartis Pharmaceuticals300 enrolled16 locationsNCT07142265
Recruiting
Not Applicable

EMDR Treatment in PTSD Following Cardiac Events

Eye Movement Desensitization and ReprocessingMyocardial InfarctionPosttraumatic Stress Disorder
University of Zurich60 enrolled1 locationNCT04672551
Recruiting
Not Applicable

OCT Versus Angiography for Culprit Lesion Revascularization in Acute Myocardial Infarction PatiEnts

Myocardial InfarctionST Elevation Myocardial Infarction
Chonnam National University Hospital1,500 enrolled18 locationsNCT06227754
Recruiting
Phase 2

Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction

Myocardial InfarctionSTEMI (ST Elevation MI)Reperfusion Injury+1 more
Nyrada Pty Ltd300 enrolled6 locationsNCT07362446
Recruiting

TROPOnin FRAGMentation in Myocardial Injury Study

Acute myocardial infarction (Type 1)Myocardial Injury
University of Turku1,500 enrolled2 locationsNCT04465591
Recruiting
Phase 2

Effect of Montelukast on Inflammatory Markers and Cardiac Injury in Patients With Acute Myocardial Infarction

Acute Myocardial Infarction (AMI)
October 6 University80 enrolled1 locationNCT07537868
Recruiting

PERIODONTAL HEALTH IN PATIENTS ACUTELY ADMITTED FOR MYOCARDIAL INFARCTION: A CASE CONTROL STUDY

PeriodontitisMyocardial Infarction, Acute
University of Aberdeen320 enrolled1 locationNCT04719026